Search Results 1351-1360 of 9393 for Endemic
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products ...
If you're at risk of heart disease, your healthcare team might use the pooled cohort equation (PCE) tool to determine your long-term risk and whether taking ...
The purpose of this study is to determine if emixustat hydrochloride (emixustat) reduces the rate of progression of macular atrophy (MA) compared to placebo in ...
ROCHESTER, Minn. — At Mayo Clinic, cardiologists Peter Noseworthy, M.D., and John Giudicessi, M.D., Ph.D., are uncovering the earliest signs of a genetic heart ...
Genetic technology has the potential to significantly improve human health by improving disease risk prediction and guiding prevention strategies. The ...
A recent Mayo Clinic study highlights the link between glucocorticoid dosage and outcomes in patients with lupus nephritis, a type of kidney inflammation caused ...
This phase II trial studies how well sapanisertib works in treating patients with pancreatic neuroendocrine tumor that has spread to other places in the ...
Latest stories · Convalescent plasma antibody levels and the risk of death from COVID-19 featured image · Diverse ways regenerative medicine is advancing health ...
The primary aim of this study is to determine if the addition of an individual polygenic risk score (PRS) in addition to the Breast Cancer Risk Assessment ...
About this study. This ComboMATCH patient registration trial is the gateway to a coordinated set of clinical trials to study cancer treatment directed by ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!